Primer Management, LLC
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- HQ
- CA
Primer Management, LLC is associated with Primer Ventures, which invests in early-stage life science tools and therapeutics companies. Its portfolio includes Curio Bioscience, which was acquired by Takara.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Biotech, Life sciences and research tools | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Primer Ventures I, LP Primer Ventures invests in early-stage life science tools and therapeutics companies, focusing on breakthrough innovations in areas such as genomics, synthetic biology, molecular diagnostics, cell and gene therapies, and AI-enabled drug discovery. Inferred from the firm's website | 2023 | $17.1M (Form D) | Open, writing first checks |
| Primer Sazze Fund II, LP | 2021 | $5.35M (Form D) | Follow-ons only |
03 · People across funds
- Greg Kim, Member of the General Partner
Primer Sazze Fund II, LP (Named on Form D)
- Kiha Lee, Member of the General Partner
Primer Sazze Fund II, LP (Named on Form D)
- Sukhyun Kim, Member of the General Partner
Primer Sazze Fund II, LP (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://www.primerventures.com
- https://www.primerventures.com/portfolio
- https://www.primerventures.com/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026